Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Director dealings: Fevertree CEO spends £1m after disappointing update

(Sharecast News) - Fevertree Drinks was at the top of the list of director buys on Friday, after its co-founder and chief executive splashed on over £1m of shares. The maker of tonics and other fizzy mixers said Tim Warrilow bought 115,000 shares for 870.89p each, spending a total of £1,001,520.04, in a single market trade.

It came after its shares tumbled at the open, as the firm downgraded its full-year profit guidance amid higher costs and highlighted an "exceptionally challenging" environment.

The group said the impact of logistics and cost headwinds has significantly worsened in recent months, with it now expecting gross margins of around 37% and an EBITDA margin of about 14% for the first half.

Elsewhere, Litigation Capital Management disclosed a purchase worth more than £0.2m made by its chairman.

The company said Jonathan Moulds bought 250,000 shares on Thursday for 87.4p apiece, valuing the transaction at £218,500.

Following the purchase, LCM said Moulds had an interest in 2,330,000 of its shares, representing 1.95% of its issued capital.

Reporting by Josh White at Sharecast.com.

Top Director Buys

Fevertree Drinks (FEVR) Director name: Warrillow ,Timothy (Tim) Daniel Amount purchased: 115,000 @ 870.89p Value: £1,001,520.04

Litigation Capital Management Limited (di) (LIT) Director name: Moulds,Jonathan Amount purchased: 250,000 @ 87.40p Value: £218,500.00

Lxi Reit (LXI) Director name: Seaborn,Hugh Amount purchased: 20,500 @ 145.95p Value: £29,919.75

Cmo Group (CMO) Director name: Packer,Suzanne Amount purchased: 40,000 @ 37.89p Value: £15,156.00

Amaroq Minerals Ltd. Npv (di) (AMRQ) Director name: Neuhauser,David Loren Amount purchased: 31,200 @ $0.63 Value: $11,628.71

Appreciate Group (APP) Director name: Parsons,Guy Paul C Amount purchased: 26,455 @ 27.23p Value: £7,202.43

Appreciate Group (APP) Director name: Cabrini ,Sally Amount purchased: 20,000 @ 27.35p Value: £5,470.00

Appreciate Group (APP) Director name: Parsons,Guy Paul C Amount purchased: 10,161 @ 27.30p Value: £2,773.95

Amaroq Minerals Ltd. Npv (di) (AMRQ) Director name: Neuhauser,David Loren Amount purchased: 4,500 @ $0.63 Value: $1,677.22

National Grid (NG.) Director name: Pettigrew,John Amount purchased: 14 @ 1,089.00p Value: £152.46

National Grid (NG.) Director name: Agg,Andrew Amount purchased: 14 @ 1,089.00p Value: £152.46

Share this article

Related Sharecast Articles

Director dealings: British American Tobacco's Karen Guerra purchases shares
(Sharecast News) - British American Tobacco revealed on Thursday that non-executive director Karen Guerra had acquired 6,000 ordinary shares in the FTSE 100-listed tobacco giant.
Director dealings: Convatec non-executive director makes share purchase
(Sharecast News) - Convatec revealed on Wednesday that non-executive director Jens Viebke had acquired 24,400 ordinary shares in the FTSE 100-listed medical products and technology firm.
Director dealings: Mortgage Advice Bureau chairman snaps up shares
(Sharecast News) - Mortgage Advice Bureau revealed on Tuesday that non-executive chairman Michael Jones had acquired 5,833 ordinary shares in the AIM-listed property finance platform operator.
Director dealings: Insig Ai CEO raises stake
(Sharecast News) - Insig Ai revealed on Monday at chief executive Richard Bernstein had acquired 400,000 ordinary shares in the AIM-listed data infrastructure and machine learning firm.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.